Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Carrick Therapeutics has raised $60.0M in total funding. The most recent round was Series C. The last funding was announced in December 2022.
Carrick Therapeutics's investors include ARCH Venture Partners, B Capital, Pfizer, Evotec, Google Ventures.
Carrick Therapeutics is headquartered in Boston, United States.
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Carrick Therapeutics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Carrick Therapeutics — Funding & Investors." VCBacked, December 1, 2022, https://www.vcbacked.co/company/carrick-therapeutics. Accessed July 20, 2026.
VCBacked. (2022). Carrick Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/carrick-therapeutics
{{cite web |title=Carrick Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/carrick-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated